The management of chronic inflammatory bowel diseases at the time of Covid, whose peak of onset is between 15 and 30 years, even if one in 5 cases is already recorded in pediatric age.
These are some of the issues that will be addressed during the 11th edition of the IG-IBD National Congress starting tomorrow in online mode.
"Covid-19 - explains a note - has pushed to the sidelines everything that was not related to the infection itself, leaving aside many chronic patients, including those suffering from IBD - Chronic Inflammatory Intestinal Diseases (Crohn's Disease and Colitis ulcerosa), who have encountered problems of assistance and availability of places such as cancer patients, cardiology patients and many others. This has accentuated already existing problems such as the diagnostic delay of these pathologies, already subtle by nature, so much so that today still there are no precise estimates of how many patients are in Italy, but only the hypothesis that they amount to between 200 and 250 thousand ".
"Even in the case of obvious symptoms of suspected ulcerative colitis, the diagnostic delay ranges from 3-6 months to 12-18 months.
Even more significant are the delays in Crohn's disease.
The consequence of this phenomenon can be serious, with degeneration, complications and surgical interventions ", underlines Marco Daperno, General Secretary IG-IBD, AO Mauritian Order of Turin.
Among the main issues that will be addressed during the Congress, the role of fibrosis in IBD, the positioning of drugs, the overlap between irritable bowel and IBD, gender medicine, cross-sectional imaging, ultrasonography, techniques of artificial intelligence applied in endoscopy.
